DK213286A - 2-pyrrolidonderivater, fremgangsmaader til deres fremstilling, samt deres anvendelse i farmaceutiske midler - Google Patents

2-pyrrolidonderivater, fremgangsmaader til deres fremstilling, samt deres anvendelse i farmaceutiske midler

Info

Publication number
DK213286A
DK213286A DK213286A DK213286A DK213286A DK 213286 A DK213286 A DK 213286A DK 213286 A DK213286 A DK 213286A DK 213286 A DK213286 A DK 213286A DK 213286 A DK213286 A DK 213286A
Authority
DK
Denmark
Prior art keywords
procedures
preparation
pharmaceutical agents
pyrrolidone derivatives
alkylene
Prior art date
Application number
DK213286A
Other languages
Danish (da)
English (en)
Other versions
DK213286D0 (da
Inventor
Hironori Ikuta
Youji Yamagishi
Kozo Akasaka
Isao Yamatsu
Seiichi Kobayashi
Shirota Hiroshi
Kouichi Katayama
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK213286D0 publication Critical patent/DK213286D0/da
Publication of DK213286A publication Critical patent/DK213286A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK213286A 1985-05-09 1986-05-07 2-pyrrolidonderivater, fremgangsmaader til deres fremstilling, samt deres anvendelse i farmaceutiske midler DK213286A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60096799A JPH066571B2 (ja) 1985-05-09 1985-05-09 2−ピロリドン誘導体

Publications (2)

Publication Number Publication Date
DK213286D0 DK213286D0 (da) 1986-05-07
DK213286A true DK213286A (da) 1986-11-10

Family

ID=14174668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK213286A DK213286A (da) 1985-05-09 1986-05-07 2-pyrrolidonderivater, fremgangsmaader til deres fremstilling, samt deres anvendelse i farmaceutiske midler

Country Status (19)

Country Link
US (1) US4833160A (es)
EP (1) EP0204964B1 (es)
JP (1) JPH066571B2 (es)
KR (1) KR910004789B1 (es)
CN (1) CN1014058B (es)
AT (1) ATE66673T1 (es)
AU (1) AU581078B2 (es)
CA (1) CA1264762A (es)
DE (1) DE3681076D1 (es)
DK (1) DK213286A (es)
ES (1) ES8800148A1 (es)
FI (1) FI84172C (es)
HU (2) HU199117B (es)
MX (1) MX162717A (es)
NO (1) NO861820L (es)
NZ (1) NZ216092A (es)
PH (2) PH23189A (es)
PT (1) PT82540B (es)
ZA (1) ZA863352B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691367A (en) * 1985-08-09 1997-11-25 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5202341A (en) * 1987-03-11 1993-04-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Hydroxystyrene compounds having tyrosine kinase inhibiting activity
WO1988007035A1 (en) * 1987-03-11 1988-09-22 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Hydroxystyrene derivatives
US5089516A (en) * 1987-03-11 1992-02-18 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha 1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting activity
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
HU214333B (hu) * 1991-01-21 1998-03-02 Shionogi Seiyaku Kabushiki Kaisha Eljárás benzilidén-karbamoil-2-pirrolidon, -4-tiazolidinon, -4-oxazolidinon, -3-izotiazolidinon- és -3-izoxazolidinon-analógok és az ezeket tartalmazó gyógyszerkészítmények előállítására
US5270339A (en) * 1991-04-05 1993-12-14 Kanagafuchi Kagaku Kogyo Kabushiki Kaisha Phenoxybenzene derivative
ES2089736T3 (es) * 1992-10-28 1996-10-01 Shionogi & Co Derivados de bencilideno.
US5358964A (en) * 1993-07-26 1994-10-25 Warner-Lambert Company Benzylidene-lactone and their thiocarbonyl analogs as inhibitors of proteoglycan degradation
GB9704499D0 (en) 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
CN103342672B (zh) * 2013-07-02 2015-12-23 扬州大学 取代吡咯烷-2-酮的新合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714153A (en) * 1970-06-22 1973-01-30 Roussel Uclaf Novel cyclopropanecarboxylic acids
DE2329308A1 (de) * 1972-03-03 1975-01-02 Gruenenthal Chemie Neue lactame
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
US4138495A (en) * 1978-05-19 1979-02-06 Stauffer Chemical Company N-Substituted pyrrolidones and their use as miticides
JPS5879944A (ja) * 1981-11-09 1983-05-13 Kanegafuchi Chem Ind Co Ltd 3,5−ジ・タ−シヤリ−・ブチルスチレン誘導体及び抗炎症、鎮痛、解熱剤並びに血小板凝集阻害剤
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
JPS57130950A (en) * 1981-02-05 1982-08-13 Kanegafuchi Chem Ind Co Ltd 3,5-di-tert-butyl-4-hydroxystyrene derivative and anti- inflammatory, analgesic, antipyretic agent and inhibitor for blood platelet aggregation
US4440784A (en) * 1981-02-05 1984-04-03 Kanegafuchi Chemical Industry Company, Ltd. Anti-inflammatory, analgesic, and antipyretic pharmaceutical composition
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
JPS6112660A (ja) * 1984-06-27 1986-01-21 Kanegafuchi Chem Ind Co Ltd 新規2−ピロリドン誘導体及び抗炎症剤
JPH0623194B2 (ja) * 1985-03-23 1994-03-30 鐘淵化学工業株式会社 新規ラクタム誘導体及び抗炎症剤
JPS6412660A (en) * 1987-07-07 1989-01-17 Canon Kk Original reader
JP3611676B2 (ja) * 1996-06-24 2005-01-19 アサマ化成株式会社 パン生地の改良剤およびパンの製造方法

Also Published As

Publication number Publication date
DE3681076D1 (de) 1991-10-02
AU5676686A (en) 1986-11-13
EP0204964A1 (en) 1986-12-17
HUT43040A (en) 1987-09-28
KR910004789B1 (ko) 1991-07-13
ATE66673T1 (de) 1991-09-15
NZ216092A (en) 1988-08-30
FI861698A0 (fi) 1986-04-22
FI84172C (fi) 1991-10-25
US4833160A (en) 1989-05-23
HU196749B (en) 1989-01-30
ES8800148A1 (es) 1987-11-01
PT82540B (pt) 1988-08-17
AU581078B2 (en) 1989-02-09
CA1264762A (en) 1990-01-23
FI861698A (fi) 1986-11-10
HUT45493A (en) 1988-07-28
EP0204964B1 (en) 1991-08-28
NO861820L (no) 1986-11-10
CN1014058B (zh) 1991-09-25
JPS61257967A (ja) 1986-11-15
PH23225A (en) 1989-06-06
HU199117B (en) 1990-01-29
FI84172B (fi) 1991-07-15
DK213286D0 (da) 1986-05-07
ZA863352B (en) 1986-12-30
ES554775A0 (es) 1987-11-01
JPH066571B2 (ja) 1994-01-26
CN86103227A (zh) 1987-01-21
PH23189A (en) 1989-05-29
MX162717A (es) 1991-02-18
KR860008973A (ko) 1986-12-19
PT82540A (en) 1986-06-01

Similar Documents

Publication Publication Date Title
DK213286A (da) 2-pyrrolidonderivater, fremgangsmaader til deres fremstilling, samt deres anvendelse i farmaceutiske midler
DK601988D0 (da) N-substituerede derivater af 1-desoxynojirimycin og 1-desoxymannonojirimycin, fremgangsmaade til deres fremstilling samt deres anvendelse i laegemidler
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES2082805T3 (es) Derivados de tiazol, procedimientos para su produccion y composiciones farmaceuticas que comprenden los mismos.
ES2133430T3 (es) Derivados de n-heteroaril-n-fenilurea, su preparacion y utilizacion.
DK0551230T3 (da) 2-cyan-3-hydroxyenamider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler samt farmaceutiske præparater med indhold deraf
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
NO954878L (no) Pyrrolderivater
ES2189941T3 (es) Derivados de nucleosidos aciclicos.
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
IL96088A0 (en) N-substituted derivatives of 3r,4r-ethyl-((1-methyl-1h-imidazol-5-yl)methyl)-2-pyrrolidinone
DK300688A (da) Heterocycliske hydroxyethylazolderivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
ATE59294T1 (de) Stabilisierte arzneimittel.
DK23289D0 (da) Disubstituerede pyridinderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK0388049T3 (da) Penciclovirderivater til behandling af hepatitis B infektioner
DK30485A (da) Phenanthridinderivater
DK148288D0 (da) N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne
FI96856C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoketonijohdannaisten valmistamiseksi
EP0266559A3 (en) Therapeutic agent for the treatment of peptic ulcer disease
NO303829B1 (no) Nye benzylalkoholderivater, mellomprodukter, farmas°ytiske preparater inneholdende de nye forbindelsene samt deres anvendelse
DK630788A (da) N-substituerede dichlormaleinimider, fremgangsmaade til deres fremstiling samt deres anvendelse
NO303497B1 (no) Oksazolidin-derivater og farmas°ytisk akseptable salter derav, samt anti-hyperlipidemi-blanding inneholdende disse
DK221788A (da) Nitrosourinstofderivater, fremgangsmaade til fremstilling deraf samt deres terapeutiske anvendelse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment